Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Allstate Corp (ALL) vs Tilray Brands Inc (TLRY) Price & Performance

Allstate CorpTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Allstate Corp vs Tilray Brands Inc — how do they compare? Allstate Corp trades at $262.54 (market cap $68.19B), while Tilray Brands Inc trades at $4.79 (market cap $601.34M). The key difference: Allstate Corp is far larger — about 113.4× Tilray Brands Inc's market cap, and Allstate Corp pays a 1.6% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

ALLTLRY
Market Cap
$68.19B$601.34M
Sector
FinancialsHealth
52-Week High
$275.11$21.00
52-Week Low
$190.00$3.88
Enterprise Value
$76.84B$768.47M
Dividend Yield
1.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Allstate Corp

Allstate (ALL) trades at $267.00, down 2.95% on the day, but maintains a bullish technical signal with strong fundamental momentum. The company reported robust Q2 2026 earnings of $8.99 per share, beating estimates, and has consistently exceeded expectations in recent quarters. Revenue growth is steady, with 2025 revenue at $67.07 billion and net income margin improving to 19.19%. The stock is attractively valued with a P/E of 5.35 and offers a dividend, with recent payouts of $1.08 per share.

The outlook for ALL is positive, driven by strong underwriting performance and earnings beats, though sustainability of peak profitability is a concern. Investment opportunity lies in its low valuation and dividend yield, but risks include potential normalization of underwriting results and competitive pressures. Analyst consensus is mixed with a $266.54 price target, indicating limited near-term upside from current levels.

Tilray Brands Inc

TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.

Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Allstate Corp

On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.

Read more on ALL

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY